| BIVI Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the BIVI shares outstanding history going back to 9/18/2020:
Also see: BIVI Market Cap History BIVI YTD Return |
As of 5/11/2026 BioVie has 7.54 million BIVI shares outstanding. Investors often track the BIVI shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows BIVI share count trends over time, with 24 historical shares outstanding datapoints presented, dating back to 9/18/2020.

| BIVI Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the BIVI shares outstanding history going back to 9/18/2020:
Also see: BIVI Market Cap History BIVI YTD Return |
| BIVI Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||
BIVI Historical Shares Outstanding: +103.98% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| BIVI Stock Price Chart |
| About BioVie Inc |
| BioVie Inc. is a clinical-stage company engaged in developing drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease. In neurodegenerative disease, the Co.'s drug candidate NE3107 inhibits inflammatory activation of extracellular single-regulated kinase (ERK) and nuclear factor kappa-light-chain-enhancer of activated B cells (NFkB) that leads to neuroinflammation and insulin resistance, but not their homeostatic functions. In liver disease, its orphan drug candidate BIV201 (continuous infusion terlipressin) is for the treatment of refractory ascites due to liver cirrhosis. BIV201 is administered as a liquid formulation. We show 24 historical shares outstanding datapoints in our coverage of BIVI's shares outstanding history. Understanding the changing numbers of BIVI shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like BIVI versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching BIVI by allowing them to research BIVI shares outstanding history as well as any other stock in our coverage universe. |
| BIVI Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| BIVI Share Performance |
| Shares Outstanding Peers |
| BioVie (BIVI) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
BJDX Shares Outstanding History BKD Shares Outstanding History BLCM Shares Outstanding History BLFS Shares Outstanding History BLI Shares Outstanding History BLPH Shares Outstanding History BLRX Shares Outstanding History BLUE Shares Outstanding History BMEA Shares Outstanding History BMRA Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.